AP21590PU-S
antibody from Acris Antibodies GmbH
Targeting: BCL2L1
Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52
Antibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AP21590PU-S - Provider product page

- Provider
- Acris Antibodies GmbH
- Proper citation
- Acris Antibodies GmbH Cat#AP21590PU-S, RRID:AB_10756586
- Product name
- anti Bcl-2-like 1
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to amino acids 61-79 (DSPAVNGATAHSSSLDARE) of human Bcl-XL
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 50 µl
No comments: Submit comment
Supportive validation
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image

- Experimental details
- Formalin-fixed paraffin-embedded section of dog ischemic brain cortex stained for Bcl-X expression using AP21590PU-S at 1/2000. At 2 hr post ischemia, Bcl-X staining was seen in the dying neurons that had morphological features of apoptosis (arrows). In contrast, mophologically normal appearing neurons lacked Bcl-X staining (arrowheads). Hematoxylin-eosin counterstain.
- Submitted by
- Acris Antibodies GmbH (provider)
- Main image

- Experimental details
- Formalin-fixed paraffin- embedded human tissue sections stained for Bcl-X expression using AP21590PU-S at 1/2000. A. Cortex from the brain of an Alzheimer's disease patient. The degenerating neurons are positive for BclX expression, the intact neurons are not. B. Normal bone marrow. The cells positive for Bcl-X expression appear to be of erythropoetic lineage. Hematoxylin-eosin counterstain.